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Abstract
Growth factors of the gp130 family promote oligodendrocyte differentiation, and viability,
and myelination, but their mechanisms of action are incompletely understood. Here, we
show that these effects are coordinated, in part, by the transcriptional activator Krüppel-like
factor-6 (Klf6). Klf6 is rapidly induced in oligodendrocyte progenitors (OLP) by gp130 fac-
tors, and promotes differentiation. Conversely, in mice with lineage-selective Klf6 inactiva-
tion, OLP undergo maturation arrest followed by apoptosis, and CNS myelination fails.
Overlapping transcriptional and chromatin occupancy analyses place Klf6 at the nexus of a
novel gp130-Klf-importin axis, which promotes differentiation and viability in part via control
of nuclear trafficking. Klf6 acts as a gp130-sensitive transactivator of the nuclear import fac-
tor importin-α5 (Impα5), and interfering with this mechanism interrupts step-wise differentia-
tion. Underscoring the significance of this axis in vivo, mice with conditional inactivation of
gp130 signaling display defective Klf6 and Impα5 expression, OLP maturation arrest and
apoptosis, and failure of CNS myelination.
Author Summary
Myelin, a membranous sheet that surrounds the axons of neurons and facilitates the trans-
mission of nerve impulses, is formed by oligodendrocytes in the central nervous system
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(CNS), and Schwann cells in the peripheral nervous system (PNS). Failure to myelinate, or
demyelination, produces the symptoms of serious diseases such as leukodystrophies and
multiple sclerosis. This study identifies a novel and essential regulator of myelin formation
in the CNS: the transcriptional activator Krüppel-like factor-6 (Klf6). We show that Klf6
acts as a control point through which pro-myelinating signals regulate the development of
oligodendrocytes from oligodendrocyte progenitor cells. Growth factors of the gp130 fam-
ily are known to promote differentiation and survival of oligodendrocytes, via activation
of the transcription factor Stat3, but the mechanistic details of how they do it remain
unclear. Our findings show that Klf6 is induced in oligodendrocyte progenitors by gp130
growth factors, and promotes differentiation. Furthermore, oligodendrocyte progenitor
cells in which Klf6 is inactivated do not mature, fail to form myelin, and eventually die.
We also uncover that upon gp130 signaling, Klf6 activates the nuclear import factor
importin-α5 (Impα5), a key controller of trafficking into the nucleus in the CNS. Notably,
inactivation of Impα5 recapitulates the features of silencing Klf6, whereas Impα5 expres-
sion can partially rescue differentiation in Klf6-deficient oligodendrocyte progenitors.
Finally, inactivation of Stat3 in oligodendrocyte progenitors produces defective Klf6 and
Impα5 expression and myelination failure, strongly resembling the features produced by
Klf6 inactivation. Collectively, these results establish a connection between gp130-Stat3
signaling and importin-based control of nuclear trafficking, which is essential for myelina-
tion in the CNS, and places Klf6 as a key coordinator of these events.
Introduction
Myelin is essential for efficient nerve impulse transmission [1], and myelination failure, or
demyelination, produces the symptoms of leukodystrophies and multiple sclerosis (MS) [2,3].
Remyelination restores conduction in MS, but is inefficient and fails in the latter stages of the
disease [4]. Therapies that promote myelin formation are not yet available. A key goal in leuko-
dystrophy and MS research is their successful translation to the clinic.
Within the central nervous system (CNS), myelin is formed by oligodendrocytes (OL),
which differentiate from specified progenitors (OLP) [5]. The number of OL available for mye-
lination is dependent on their viability and proliferation. Intrinsic transcriptional programs
drive oligodendrocyte development and are influenced by extrinsic pro-myelinating or inhibi-
tory cues [5]. Extrinsic pathways promoting differentiation include those triggered by PI3ki-
nase-mTOR, Erk1/2, gp130-Stat3, and thyroid hormone (T3)/RXR signaling, and some of
these also support viability [6–11]. Conversely, inhibitory cues for differentiation include those
driven by Bmp and canonical Notch and Wnt signaling [5,12]. However, the mechanisms by
which extrinsic signals influence myelination are incompletely characterized. Elucidating these
mechanisms may identify key control points in oligodendrocyte development, manipulation of
which may be used to promote myelin formation and repair.
Here, we now show that the pro-myelinating effects of gp130-Stat3 signaling are coordi-
nated in part by Krüppel-like factor-6 (Klf6), a transcriptional activator of the Klf/Sp family.
Members of this family are characterized by three C2H2-type zinc fingers that recognize GC-
rich consensus motifs, and they act in combination to produce additive, synergistic, or differen-
tial outcomes [13]. Klf1, Klf4, and Klf5 have been shown to regulate hematopoietic, epidermal,
and cardiovascular differentiation [14–16], and in different settings Klf4 also promotes stem
cell maintenance [17]. Klf6 has been characterized as a tumor suppressor in prostate, ovary,
liver, and gut [18], and Klf4, Klf5, and Klf6 are also implicated as regulators of viability [13]. In
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the CNS, Klf4 and Klf7 have been shown to regulate neuronal morphogenesis [19,20]. Klf15
has been found to promote astrocyte differentiation [21], and in oligodendrocytes, Klf9 has
been identified as a T3-sensitive regulator of myelin repair. Klf9-/- mice show delayed CNS
remyelination, although they display no clear developmental myelination defects [22].
Our data identify Klf6 as required for developmental CNS myelination, and show that it
coordinates pro-myelinating effects of the gp130-Stat3 pathway. Moreover, our findings sug-
gest that gp130-Stat3-Klf6 signaling promotes viability and differentiation in part via control of
nuclear trafficking. Klf6 acts as a gp130-sensitive transactivator of the nuclear import factor
importin-α5 (Impα5), and interfering with this mechanism interrupts step-wise differentia-
tion, with subsequent apoptosis. Underscoring the significance of the gp130-Klf-importin axis
in myelination in vivo, our results show that mice with conditional inactivation of Klf6 or
canonical gp130-Stat3 signaling in the oligodendrocyte lineage display defective Impα5 regula-
tion, maturation arrest followed by apoptosis, and failure of CNS myelination.
Results
Klf6 Is Induced by Extrinsic Pro-myelinating gp130-Stat3 Signaling in
Oligodendrocyte Progenitors
In the developing CNS, oligodendrocyte lineage cells are Olig2+, and OLP co-express the pro-
teoglycan Ng2/Cspg4, SRY-box transcription factor 9 (Sox9), and mitogen receptor Pdgfrα
(Fig 1A). Differentiation to the postmitotic immature oligodendrocyte (iOL) stage is marked
by loss of OLP markers, co-expression of the transcription factor Nkx2.2 [23], and induction of
adenomatous polyposis coli (Apc) and O4 [5]. Subsequently, iOL undergo terminal differentia-
tion to become mature oligodendrocytes (mOL), which are extensively arborized and express
the myelin proteins Cnp, Mag, Mbp, and Mog [5].
Initial data suggesting a role for Klf6 in oligodendrocyte development came from screening
for responses to pro-myelinating signals in the mouse OLP line Oli-neu [24] and primary OLP
[25]. Amongst Klf family members known to be CNS-expressed, Klf6 and Klf7 were upregu-
lated by the gp130 ligands Cntf and Lif, while Klf9 was sensitive to T3 [22] and Klf10 was upre-
gulated by ligands for both pathways (Figs 1B and S1A). Klf6 displayed the most rapid and
sustained response to gp130 factors, detectable by 1 h and persisting through 3 h. Cntf induc-
tion of Klf6 was dependent on Jak-Stat signaling, and resulted in nuclear translocation (Fig 1C
and 1D). Based on these data, our attention was directed to Klf6 as a potential effector of pro-
myelinating gp130 signals.
Klf6 Is Downregulated during OLP Differentiation and Is Essential to
Successful CNS Myelination
We examined Klf6 expression in the developing spinal cord, a well-characterized system for
studying myelination [5]. Confocal imaging of early postnatal (P1–14) samples revealed het-
erogeneous expression by Olig2+ cells, and more homogeneous astrocytic and neuronal immu-
noreactivity (Fig 1E). The source of heterogeneity in the oligodendrocyte lineage was revealed
by staining for stage-specific markers, which showed that Klf6 is downregulated during differ-
entiation. Klf6 was highly expressed in OLP, whereas immunoreactivity was low or absent in
more mature Apc+ iOL and was not observed in mature Mag+ cells (Fig 1F).
To determine the functional significance of Klf6 in oligodendrocyte development, we used
conditional inactivation in vivo. Importantly, these studies revealed that Klf6 is required for
CNS myelination. To inactivate Klf6 throughout the lineage, we crossed a floxed allele [26]
with Olig1Cre [27] to generate experimental Olig1Cre:Klf6fl/fl mice and three control genotypes
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Fig 1. Klf6 is induced by gp130-Stat3 signals and is required for CNSmyelination. (A) Stage-specific markers in differentiation. Following
specification to the Olig2+ oligodendrocyte lineage, oligodendrocyte progenitors (OLP) express Ng2, Sox9, and Pdgfrα. Pro-myelinating signals induce
differentiation to immature oligodendrocytes (iOL), marked by co-expression of Nkx2.2 and acquisition of Apc and O4. These undergo terminal
differentiation to mature OL, which express myelin proteins. (B) Klf/Sp family responses to the pro-myelinating factors Cntf (100ng/ml) and T3 (40ng/ml),
as determined by quantitative PCR (qPCR). (C) Immunoblotting for Klf6 in Oli-neu cultures pretreated with 0–1,000 nM Jak Inhibitor I 2 h, then exposed to
100 ng/ml Cntf 1 h. (D) Confocal imaging for Klf6 and the gp130 effector Stat3 in mouse OLP exposed to 100 ng/ml Cntf or vehicle 1 h. Cntf upregulation
of Klf6 is associated with translocation to the nucleus, where it colocalizes with Stat3. (E,F) Klf6 expression visualized via confocal imaging in vivo. (E) In
the postnatal CNS (spinal cord shown), immunoreactivity is heterogeneous in Olig2+ cells and more homogeneous in astrocytes (Gfap+) and neurons
(NeuN+). Boxes and arrows highlight representative cells. (F) Klf6 is highly expressed (arrowheads) in OLP (left panel). In contrast, expression is lower
Klf6 Is Required for CNSMyelination
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(Olig1Cre:Klf6fl/+, Klf6fl/fl, Klf6fl/+) (S1B and S1C Fig). Findings were confirmed using an alter-
nate Cre cassette (see Fig 2). We further compared the results of astrocyte-selective inactiva-
tion, generated using Klf6fl andmGfapCre (S1B and S1C Fig) [28].
Initial results came from Olig1Cre:Klf6fl/fl andmGfapCre:Klf6fl/fl lines. Specificity and effi-
ciency of inactivation in each line were confirmed by confocal imaging for lineage markers
(S1D Fig), and data from these studies were compatible with previously reported findings for
both cassettes [27,28]. In each breeding program, experimental pups appeared normal at birth,
but from the second postnatal week, Olig1Cre:Klf6fl/fl pups displayed progressive tremor and
ataxia (Fig 1G and S1 Video). Examination of gross pathology at P14 revealed severe CNS
hypomyelination in Olig1Cre:Klf6fl/fl mice (Fig 1H). No Olig1Cre:Klf6fl/fl pups survived the
third postnatal week, death occurring due to seizures consequent to the myelination defect. In
contrast,mGfapCre:Klf6fl/fl pups showed normal weight gain, behavior, and survival, and a nor-
mal-appearing CNS (Fig 1H), suggesting a non-critical role for Klf6 in astrocyte development.
We confirmed hypomyelination using confocal imaging. At P14, myelin proteins were pres-
ent in controls but absent in Olig1Cre:Klf6fl/fl samples in all tracts examined, including spinal
cord, hindbrain, cerebellum, corpus callosum, and optic nerves (Figs 1I 1J, S2A, S2B and S3A–
S3D). In contrast, we detected no neuronal or astrocytic pathology (S2C, S2D, S3E and S3F
Figs). We validated these data using light and electron microscopy, which confirmed selective
loss of CNS myelin sheaths (Figs 1K, 1L, S2E–S2K and S3G–S3I), whereas peripheral nerves
were myelinated normally (Figs 1I and S2J). Myelination failure persisted for the lifespan of
Olig1Cre:Klf6fl/fl mice, and was not associated with axonal pathology, even shortly prior to
death (S2K Fig).
Oligodendrocyte Transcripts Are Selectively Lost from the CNS of
Olig1Cre:Klf6fl/ffl Mice
BeadArray transcriptional profiling confirmed selective loss of oligodendrocyte transcripts
from the CNS of Olig1Cre:Klf6fl/fl mice. Comparison of Olig1Cre:Klf6fl/fl and Klf6fl/fl CNS at P1
identified 51 differentially expressed transcripts (Q< 0.05), all but one of which were reduced
in Olig1Cre:Klf6fl/fl samples (S4A Fig). Using a published database [29], we confirmed all
reduced transcripts as oligodendrocyte lineage-expressed, and 26 as lineage-specific. Gene
ontology analysis using Ingenuity software mapped the cohort to myelin morphology, oligo-
dendrocyte maturation, and myelination. Disease association identified hypomyelination, the
MS model EAE, Pelizeus-Merzbacher leukodystrophy, and demyelination (Fig 1M).
Selective Loss of Differentiating Oligodendrocytes from the CNS of
Olig1Cre:Klf6fl/fl Embryos
Transcriptional profiling of entire CNS data did not distinguish between changes in expression
in living cells, versus global changes in expression due to loss of the cells that normally express
(arrowhead) or undetectable (asterisks) in more mature Apc+ iOL (center panel), and Klf6 is not seen in mature Mag+ cells (right panel). (G) Still from S1
Video comparing a P11Olig1Cre:Klf6fl/fl mutant (cko, right) with sex-matched Klf6fl/fl littermate (ctrl, left). The mutant is ataxic. (H) CNS white matter tracts
in P14Olig1Cre:Klf6fl/fl mice display hypomyelination (arrowed), whereasmGfapCre:Klf6fl/fl mice and Klf6fl/fl littermate controls show no gross
abnormalities. Brains are shown at the samemagnification (scale bar, upper right). See S1 Fig. (I,J) Confocal analysis of lumbar spinal cords of P14
Olig1Cre:Klf6fl/fl andmGfapCre:Klf6fl/fl mice and Klf6fl/fl controls. Myelin proteins are almost absent fromOlig1Cre:Klf6fl/fl spinal cord, whereas the
peripheral nervous system (PNS) appears normal (arrowed). See S2 and S3 Figs. (K,L) Electron micrographs of P14Olig1Cre:Klf6fl/fl and Klf6fl/fl spinal
cords and optic nerves. Almost no myelin sheaths are present inOlig1Cre:Klf6fl/fl CNS samples. (M)Gene ontology of BeadArray profiling of P1 CNS from
Olig1Cre:Klf6fl/fl pups and sex-matched Klf6fl/fl littermates. The five most significant results are shown for physiologic and disease relevance. See also S4
Fig. Data are mean ± SEM. Statistics: (B,J) ANOVA plus Bonferroni test, *p < 0.05, ** p < 0.01, *** p < 0.001. Data are representative of two to four mice
per genotype (for confocal imaging data) or three mice per genotype (for electron microscopy data). Scale, (A) 5 μm, (E) 20 μm, (F) 10 μm, (H) 3 mm (I)
150 μm, inset 15 μm. Magnifications, (K) x5,000, inset x20,000, (L) x3,000. Individual values are in S1 Data.
doi:10.1371/journal.pbio.1002467.g001
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Fig 2. ConditionalKlf6 inactivation in vivo causes selective loss of differentiating oligodendrocytes. (A–F)Confocal and morphometric analysis of
oligodendrocyte numbers in developingOlig1Cre:Klf6fl/fl and control Klf6fl/fl spinal cords. Panel (A) shows samples from E12.5, immunostained for Olig2
and either Mnr (upper panels) or NeuN (lower panels). At E12.5, Olig2+ numbers inOlig1Cre:Klf6fl/fl and control samples are identical, and no differences
are seen in neuronal markers. In controls, Olig2+ cell numbers then increase from E16.5 through P14, but no increase is seen inOlig1Cre:Klf6fl/fl samples
(B–D). Areas outlined in panel (B) are shown at higher magnification, inset. See also S4B Fig. At P1, myelin proteins are expressed in controls, but not in
Olig1Cre:Klf6fl/fl spinal cords (C). (E,F) Analysis of stage-specific markers. Early events in differentiation, such as Nkx2.2 co-expression at E14.5, occur
normally inOlig1Cre:Klf6fl/fl mice, but differentiating cells are selectively lost at subsequent timepoints (E). In contrast, numbers of Olig2+Sox9+ OLP
remain identical to controls (F). There are no changes in Mnr+ motor neurons, which share the same origin as ventral OLP in the pMN domain (A upper
panels,B, G). (H,I) Selective loss of differentiating cells is associated with increased apoptosis (H), but OLP proliferation is unaffected (I). (J–L) Postnatal
stage-specific analysis confirms absence of differentiating (Apc+) oligodendrocytes fromOlig1Cre:Klf6fl/fl mice (J,L), whereas OLP (Olig2+Ng2+) numbers
are comparable to controls (K,L). Representative cells are arrowed. (M) Analysis of NG2creER–:Klf6fl/fl mice, in which Klf6 inactivation is inducibly
Klf6 Is Required for CNSMyelination
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the transcript. Therefore, to identify underlying cellular events, we used confocal imaging of
developing thoracolumbar spinal cord (Figs 2 and S4). At E12.5, following OLP specification,
through expansion at E14.5, Olig2+ cell numbers in Olig1Cre:Klf6fl/fl samples were identical to
controls (Fig 2A and 2D). Early events in differentiation, such as Nkx2.2 co-expression at
E14.5, occurred normally (Fig 2E). However, while Olig2+ cells then increased in controls, no
increase occurred in Olig1Cre:Klf6fl/fl mice (Fig 2B–2D). Remaining Olig2+ cells displayed a
typical spatial distribution, indicating normal migration and dorsal specification (Fig 2B and
2C). Myelin proteins were seen from P1 in controls, but not in Olig1Cre:Klf6fl/fl samples (Fig
2C). Heterozygotes showed no pathology or behavioral defects (S4B Fig).
Critically, further analysis revealed that the reduction in Olig2+ cells in Olig1Cre:Klf6fl/fl
samples was caused by selective loss of differentiating Olig2+Nkx2.2+, or Olig2+Apc+, cells (Fig
2E). In contrast, numbers of Olig2+Sox9+ (or Olig2+Ng2+) OLP were identical to controls (Fig
2F). There were no changes in NeuN+ neurons, or in Mnr+ motor neurons, which share the
same origin as ventral OLP in the pMN domain (Fig 2A, 2B and 2G) [27]. Loss of differentiat-
ing cells occurred via apoptosis (Fig 2H). In contrast, OLP proliferation was normal (Fig 2I).
Postnatal analysis confirmed persistent absence of maturing oligodendrocytes in Olig1Cre:
Klf6fl/fl mice, whereas OLP numbers remained equal to controls (Fig 2J–2L).
We validated specificity of the hypomyelination phenotype using a second Cre driver,
NG2creERTM, which produces inducible recombination in OLP in vivo [30]. Cre was induced
at E12.5 and embryos harvested at E18.5. Olig2+Apc+ oligodendrocytes were selectively lost in
NG2creERTM:Klf6fl/fl samples (Figs 2M, S4C and S4D).
Klf6 Promotes Oligodendrocyte Differentiation and Viability
To investigate cellular mechanism in more detail, we used mouse OLP cultures and the Oli-
neu line (Figs 3 and S4). Initially, we examined Klf6 expression during differentiation. In Oli-
neu cells and OLP, exposure to Cntf or T3 produced comparable rates of differentiation. In
Cntf- but not T3-treated cultures, this was associated with Klf6 upregulation (S4E Fig). In both
sets of cultures, Klf6 then decreased to baseline, coincident with differentiation (S4F Fig) and
matching the pattern in developing white matter (see Fig 1F).
We tested the functional impact of Klf6 silencing in mouse OLP in vitro. Cultures were
nucleofected with Klf6 siRNA or non-targeting (NT) control (see S4G Fig), then exposed to
pro-myelinating signals and harvested for confocal imaging at 24 h intervals. Silencing pro-
duced no effect on the rate of proliferation in OLP cultures prior to differentiation (Fig 3A),
nor on the rate of cell cycle exit index (Ki67-BrdU+/BrdU+) in differentiating cultures (Fig 3B).
Moreover, early events in differentiation, such as Nkx2.2 co-expression, occurred normally
in Klf6-silenced cultures, and the percentage of these cells in silenced cultures and controls
remained similar, compatible with our findings from Olig1Cre:Klf6fl/fl mice (Fig 3C and see Fig
2E). However, expression of markers of subsequent stages of differentiation, such as O4 and
Apc, was delayed in silenced cultures, and this effect was statistically significant from 24 h (Fig
3D and 3F). Moreover, silenced cultures displayed failure of terminal differentiation to Mbp+
mOL (Fig 3E and 3F). These effects were associated with increased apoptosis, which was prom-
inent by 72 h, and, interestingly, these outcomes occurred whether differentiation was induced
using Cntf or T3 (Fig 3G and 3H).
targeted to OLP. See also S4C and S4D Fig. Similar toOlig1Cre:Klf6fl/fl embryos, these mice also display selective loss of differentiating
oligodendrocytes. Data are mean ± SEM. Statistics, (D–I,L) ANOVA plus Bonferroni post test, (M) Student’s t test, ***p < 0.001. Scale: (A,B) 100 μm,
inset 20 μm, (C) 250 μm, (J,K) 10 μm. Data shown are from lumbar sections of two to six mice per genotype per timepoint. Thoracic sections showed
compatible findings. Individual values are in S1 Data.
doi:10.1371/journal.pbio.1002467.g002
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Fig 3. Klf6 is required for differentiation regardless of the initiating stimulus. (A–H)Results of confocal analysis of primary mouse OLP subjected to
Klf6 silencing as described in Materials and Methods, and treatments indicated. Klf6 silencing has no effect on active proliferation, shown by BrdU
immunoreactivity in proliferating cultures (A), nor on cell cycle exit index (Ki67-BrdU+/BrdU+) in differentiating OLP cultures (B). (C–F) Early events in
differentiation, such as Nkx2.2 co-expression, occur normally in Klf6-silenced OLP differentiated with either 40 ng/ml T3 or 100 ng/ml Cntf (C). However,
expression of markers of subsequent stages of differentiation, such as O4 and Apc, is delayed in silenced cultures compared with non-targeting (NT)
controls, and these cultures fail to mature to Mbp+ mOL (D–F). See also S4G Fig. These changes are associated with increased apoptosis (G,H). (I–L)
Confocal imaging analysis of primary mouse OLP nucleofected with GFP-labeled Klf6-overexpression construct or GFP vector control, and either left
untreated or exposed to 40 ng/ml T3 for 72 h. Klf6 overexpression accelerates differentiation triggered by a pro-myelinating signal (T3), as measured by
induction of O4 and Mbp (I–K). However, Klf6 overexpression alone does not initiate differentiation (L). (M-O)Confocal imaging analysis of Klf6-silenced
and NT control mouse OLP pretreated with 2 μM caspase inhibitor Q-VD-OPh or vehicle for 2 h, then differentiated with T3 for 48 h. Apoptosis is almost
absent from cultures exposed to the inhibitor, and Olig2+ cell numbers in Klf6-silenced and control conditions are almost identical (M,N). However, rescue
of viability does not restore differentiation, as measured by the percentage of O4+ cells (M,O). Statistics, (A,E,G,J,K,L) Student’s t test, (B,C,D,H,N,O)
ANOVA plus Bonferroni post-test, *p < 0.05, **p < 0.01, ***p < 0.001. Data are representative of at least three independent studies in separate cultures.
Individual values are in S1 Data.
doi:10.1371/journal.pbio.1002467.g003
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These data suggested that while Klf6 is regulated by some pro-myelinating factors (Cntf,
Lif) but not others (T3), its presence is required for differentiation, regardless of the initiating
stimulus. Klf6 inactivation has no effect on OLP proliferation or cell cycle exit, or on the earliest
stages of differentiation. The impact of its loss is first observed during the latter phases of dif-
ferentiation to the O4+Apc+ iOL stage, and subsequent progression to terminal maturation
fails. These events are associated with apoptosis of affected cells. Thus, Klf6 appears to function
in the early stages of differentiation, after cell cycle exit but before more terminal stages of
maturation.
Klf6 Overexpression Accelerates Differentiation
We tested the impact of Klf6 gain of function on differentiation in vivo. We nucleofected OLP
with a GFP-tagged Klf6 overexpression vector or GFP-empty control, then exposed to T3 or
vehicle control and harvested at 24 h intervals for confocal imaging analysis. Importantly,
increasing Klf6 in differentiating cultures accelerated differentiation, as measured by induction
of O4 and Mbp (Fig 3I–3K). However, Klf6 overexpression alone did not initiate differentia-
tion, in that it did not trigger acquisition of differentiation markers in the absence of an extrin-
sic pro-myelinating signal (Fig 3L).
Rescue of Viability in Klf6-Deficient Cultures Does Not Restore
Differentiation
Since we detected apoptosis of differentiating cells in Klf6-silenced cultures, we tested whether
Klf6 acts primarily on differentiation or viability, or independently on both. We grew Klf6-
silenced and NT control mouse OLP in the presence of the caspase inhibitor Q-VD-OPh 2 μM
or vehicle, then induced differentiation and harvested at 48 h. Apoptosis was almost absent in
cultures exposed to the caspase inhibitor, and numbers of Olig2+ cells were almost identical
(Fig 3M and 3N). However, inhibition of apoptosis in Klf6-silenced cultures did not rescue dif-
ferentiation (Fig 3M and 3O).
These data suggested that Klf6 plays distinct roles in differentiation and viability. Our find-
ings indicate that some pro-myelinating cues, such as gp130 signaling, use Klf6 to set the rate
of differentiation. Others, such as T3, must use alternate means to achieve a similar end. More-
over, a basal level of Klf6 is required for differentiation regardless of the initiating trigger. Inter-
estingly, these effects are compatible with roles proposed for gp130-Stat3 signaling on viability
and maturation, in the oligodendrocyte lineage and more widely [10,11,31,32].
Transcriptional Profiling Links Klf6 to Differentiation and Upstream
gp130-Stat3 Signaling
To find important molecular mechanisms by which Klf6 exerts its effects, we initially used
RNA sequencing (RNA-seq) to identify a full cohort of Klf6-regulated transcripts (Figs 4 and
S5, S1–S3 Tables). This work compared transcript numbers in Klf6-silenced versus NT control
primary mouse OLP, and O4+Apc+Mbp- iOL differentiated with T3 for 18 h (S5A and S5B
Fig). These studies identified 212 Klf6-regulated transcripts in OLP and 91 in iOL, of which 40
were shared (Fig 4A).
Analysis of this dataset supported a role for Klf6 in differentiation—almost half of the genes
identified as Klf6-sensitive have been implicated previously as regulating differentiation and/or
morphology (Fig 4B). In OLP, we identified the transcription factors Sox8, Sox9, and Sox21,
which regulate oligodendrocyte and neural progenitor differentiation [33–35]. In iOL, Klf6
also regulated Sox10, which is required for OLP maturation [36]. Additionally, in OLP we
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Fig 4. RNA sequencing identifies Klf6-dependence of gp130-driven transcriptional patterns. (A)Overview of approach used to define key Klf6
effectors. Initial RNA-seq analysis of primary mouse cultures identifies 212 unique Klf6-regulated transcripts in OLP and 91 in iOL, of which 40 are shared.
See S1–S3 Tables and S5A and S5B Fig. (B,C)Results of functional inference (B) and GO analysis (C) of RNA-seq data, from primary OLP (red), iOL
(blue), or both (purple). In (B), numbers of Klf6-regulated genes are indicated for each function. Implicated signaling pathways in OLP are presented as a
smaller Venn diagram, inset. (D) Examples of qPCR validation of RNA-seq data for select OLP, iOL, and shared genes. A larger cohort of validation data
is presented in S5C Fig. (E)Gp130 sensitivity of select validated differentially expressed transcripts. Results are shown from Oli-neu cells treated with
Cntf (100 ng/ml) for up to 24 h. Colored areas indicate the time period before peak response of Klf6 to Cntf. See also S5D Fig. (F) Klf6-dependence of
Cntf-induced responses. qPCR analysis of Klf6-silenced and control Oli-neu cells treated with Cntf for up to 24 h. Cntf sensitivity of differentially
expressed targets is blunted in Klf6-silenced samples. Note also that some genes are Cntf-independent but Klf6-dependent during differentiation. Data
are mean ± SEM. Statistics, (D) Student’s t test, (F) Two-way ANOVA plus Bonferroni post-test, *p < 0.05, **p < 0.01, ***p < 0.001. Data are
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identified the Wnt and Notch pathway components Wnt7b and Dact1, which limit differentia-
tion (Fig 4B and S1 Table) [37,38], while in iOL, Klf6 regulated the homeobox transcription
factors Arx and Dbx2, which are required for normal neural progenitor development (Fig 4B
and S2 Table) [39,40].
RNA-seq data also suggested reciprocal interactions of Klf6 and the gp130-Stat3 pathway.
We identified Klf6 regulation of the pathway components gp130, Stat-1 and -3, Jak1, and Socs2
and -3, suggesting that Klf6 exerts feedback on the pro-myelinating pathway that induces its
expression (Fig 4B and S1 and S3 Tables). Gene ontology of the RNA-seq dataset also identified
gp130 signaling as Klf6-regulated (Fig 4C). Collectively, these results suggested Klf6 as a coor-
dinator that links gp130-Stat3 signaling and differentiation.
Intriguingly, RNA-seq data also suggested potential downstream effectors through which
Klf6 might exert its actions. Notably, we identified Klf6 regulation in both OLP and iOL of
Impα5, the major controller of transcription factor nuclear import in the adult CNS [41,42].
Importins are required for success of transcriptional programs, including those controlling dif-
ferentiation and viability (Fig 4B and S3 Table) [41,43]. Thus, this finding suggested a potential
effector mechanism by which Klf6 might regulate oligodendrocyte development.
We validated this dataset using qPCR screening of a gene subset in mouse OLP and Oli-neu
cells. These studies confirmed that Klf6 silencing resulted in downregulation of gp130 pathway
components (Stat3, gp130), and transcripts associated with differentiation (Sox10, Dbx2) and
nuclear import (Impα5), and upregulation of transcripts linked to progenitor maintenance
(Arx, Sox9) (Figs 4D and S5C). Interestingly, although Sox9 helps to maintain Pdgfrα expres-
sion in progenitors [44], our data from silencing studies in vitro showed that Klf6 inactivation
(and associated increases in Sox9) was not associated with changes in OLP proliferation or cell
cycle exit (see Fig 3A and 3B). Notably, qPCR validation also extended our RNA-seq findings
in that it confirmed that Klf6 mediates responses to pro-myelinating gp130 signals. Half of vali-
dated genes identified as Klf6-regulated were also sensitive to gp130-Stat3 induction, including
Sox10 and Impα5 (Figs 4E and S5D), and these responses were Klf6-dependent (Fig 4F). The
remaining cohort was Klf6-dependent and Cntf-independent, suggesting regulation by basal
Klf6 levels that existed in OLP prior to downregulation during differentiation. This latter
cohort included several genes relevant to progenitor development and migration, including
Arx, Dbx2, the semaphorin receptor plexin B3, and the cytoskeletal adaptor Stmn3, which has
recently been linked to glioma motility (Figs 4F and S5D) [45].
Analysis of Klf6 Chromatin Occupancy Identifies a gp130-Klf-Importin
Signaling Axis
To identify genes that are directly Klf6-controlled, we used chromatin immunoprecipitation
and sequencing (ChIP-seq) to analyze Klf6 promoter occupancy, then cross-referenced the
results to the RNA-seq dataset. ChIP-seq identified 914 sites of Klf6 binding to prospective
control regions of annotated genes in OLP, and 753 in iOL, of which 337 were shared (Fig 5A
and S4 Table). Superimposing the ChIP-seq and RNA-seq data identified an overlapping
cohort of 20 genes. Notably, these included gp130 and Impα5 (Fig 5B and S5 Table).
We used this cohort as a starting point for analyses to identify the mechanism of action
of Klf6 in the oligodendrocyte lineage. Notably, this work analyzed Klf6 interactions with
upstream gp130-Stat3 signaling (Fig 5), and its interactions with potential downstream
representative of two to three independent studies. RNA-seq data are presented in full in S1–S3 Tables and are available on the GEO website (http://
www.ncbi.nlm.nih.gov/geo/) (Accession number GSE79245). Individual values for all other quantifications are in S1 Data.
doi:10.1371/journal.pbio.1002467.g004
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Fig 5. Stat3 inactivation in vivo produces failure of myelination, similar to Klf6 inactivation. (A)Graphical overview of genome-scale chromatin
occupancy (ChIP-seq) data for Klf6 in primary mouse OLP and iOL. ChIP-seq analysis identifies 577 peaks of Klf6 chromatin binding within 20 kb of
transcription start sites in OLP, 416 in iOL, and 337 that are shared. See also S4 Table. (B) Cross-referencing this ChIP-seq dataset to RNA-seq data in
S1 and S2 Tables identifies 20 genes as prospective directly-regulated Klf6 effectors. This cohort is presented in S5 Table. (C,D) ChIP-seq identifies Klf6
binding to the promoter of the gp130 gene (C), which is also amongst multiple gp130-Stat3 signaling pathway components identified by RNA-seq as
Klf6-regulated (D, and see S1–S3 Tables). These findings suggest that Klf6 exerts feedback upon the gp130-Stat3 pathway that drives its expression (E).
(F) Confocal images of spinal cords of E16.5Olig1Cre:Klf6fl/fl and Klf6fl/fl control embryos labeled for Stat3 and Olig2. Areas illustrated are from grey
matter (GM). Levels of Stat3 are reduced in the oligodendrocyte lineage inOlig1Cre:Klf6fl/fl samples. Arrowheads mark representative cells, which are
shown at higher magnification below. See also S6A Fig. (G–M) Confocal analysis of spinal cords frommice with Stat3 inactivation targeted to OLP
(Olig1Cre:Stat3fl/fl and PdgfracreERTM:Stat3fl/fl). The oligodendrocyte phenotype of these mice resembles that produced by conditional Klf6 inactivation
(see Fig 2). At E12.5–14.5, OLP numbers in conditional Stat3mutants are comparable to Stat3fl/f controls, and early events in differentiation occur
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importin effectors (Fig 6). Collectively, this work identified a gp130-Klf-importin axis that reg-
ulates oligodendrocyte viability and differentiation.
Klf6 Exerts Positive Feedback upon Upstream gp130-Stat3 Signaling
Multiple pieces of evidence supported interactions of Klf6 and upstream gp130-Stat3 signaling.
In addition to data showing gp130-mediated Klf6 induction, ChIP-seq identified Klf6 binding
to the gp130 promoter (Fig 5C), and RNA-seq revealed Klf6 regulation of multiple gp130 sig-
naling components (Fig 5D, and see S1–S3 Tables). Together, these results suggested that pro-
myelinating gp130-Stat3 effects are mediated in part via Klf6, and that Klf6 also exerts feedback
upon this pathway (Fig 5E). Our studies further suggested the link between gp130-Stat3 and
Klf6 was specific and not open to flexibility. In Stat3-silenced OLP cultures, Klf6 was Cntf-
insensitive, and no compensatory sensitivity to T3 was detected (S5E Fig).
Analysis of Klf6 regulation of gp130-Stat3 signaling in vivo supported this hypothesis. Pre-
vious studies show that Stat3 expression is dependent upon and can be used as a marker of
gp130 activity [46]. We therefore analyzed whether Klf6 inactivation impacted Stat3 expression
in Olig1Cre:Klf6fl/fl mice. In control spinal cords, expression was strongest in Mnr+ motor neu-
rons (S6A Fig), and lower-level activity was detectable more widely, including in Olig2+ cell
nuclei (Fig 5F). Importantly, Stat3 was reduced in Olig2+ cells in Olig1Cre:Klf6fl/fl samples, sug-
gesting Klf6 regulates gp130 pathway activity in oligodendrocytes in vivo (Fig 5F).
Conditional Stat3 Inactivation In Vivo Produces Failure of Myelination
and Defects in Klf6 Expression
If gp130-Stat3 signaling driving Klf6 expression is important in white matter formation, condi-
tional Stat3 inactivation should disrupt this program. To test this hypothesis, we generated
conditional Stat3 knockout mice by crossing a floxed Stat3 allele [47] with Olig1Cre. Data were
also validated using PdgfracreERTM, which, like NG2creERTM, produces inducible inactivation
in OLP [48]. In Olig1Cre:Stat3fl/fl and PdgfracreERTM:Stat3fl/fl mice, we correlated changes in
Klf6 activity with defects in oligodendrocyte development. We then compared the results of
these analyses with data from mice with selective Klf6 inactivation (Fig 5G–5M, compare with
Figs 1 and 2).
Importantly, similar to conditional Klf6 knockouts, mice with selective Stat3 inactivation
showed loss of maturing oligodendrocytes and myelination failure. At E12.5-E14.5, OLP num-
bers in Olig1Cre:Stat3fl/fl spinal cords were similar to controls, and early differentiation events
were normal (Fig 5G and 5H). However, differentiating cells were lost from E16.5 (Fig 5G–5I),
and myelination was disrupted (Fig 5J and 5K). This loss occurred via apoptosis (S6B Fig).
OLP numbers and proliferation were unaffected (Figs 5G and S6C). Notably, these effects were
accompanied by a lineage-specific defect in expression of Klf6 or Klf6-expressing cells (Fig 5L).
Interestingly, Olig1Cre:Stat3fl/fl embryos also displayed features not shared with Klf6
mutants. We detected progressive loss of viability of ventral Mnr+ motor neurons, which have
normally (G,H). However, selective loss of differentiating cells is seen from E16.5 onward (H,I), and myelination is profoundly disrupted (J,K, see also S6B
and S6C Fig). Stat3 inactivation produced byOlig1Cre also results in loss of motor neurons, which share the same origin in the pMN domain (K, and see
S6D Fig). (L) Spinal cords of E16.5Olig1Cre:Stat3fl/fl and control Stat3fl/fl embryos, labeled for Klf6 and Olig2. The border between grey (GM) and white
matter (WM) is marked, and representative cells are arrowed. Conditional Stat3 inactivation produces defective Klf6 expression. (M)Conditional Stat3
inactivation in OLP using PdgfracreERTM results in selective failure of OLP differentiation and myelination. Motor neurons are unaffected. Data are
mean ± SEM. Statistics, (G–J) ANOVA plus Bonferroni test, (M) Student’s t test, **p < 0.01, ***p < 0.001. Scalebars, (F,L) 5 μm, (K) 250 μm. Data are
representative of two to six mice per genotype per time point. Results in (F–M) are from lumbar sections. ChIP-seq data are presented in full in S4 Table,
RNA-seq and ChIP-seq intersect data are presented in full in S5 Table, and both datasets are available on the GEOwebsite (http://www.ncbi.nlm.nih.gov/
geo/) (Accession number GSE79245). Individual values for all other quantifications are in S1 Data.
doi:10.1371/journal.pbio.1002467.g005
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Fig 6. Klf6 promotes differentiation via transactivation of importin-α5. (A–C)ChIP-seq (A), qPCR (B), and confocal imaging data (C) identifying Klf6
regulation of the downstream importin effector Impα5. Data are also compatible with RNA-seq results in S1–S3 Tables. (A) ChIP-seq in primary mouse
OLP and iOL demonstrates direct Klf6 binding to the promoter region of Impα5, which RNA-seq also identifies as Klf6-regulated (see S3 Table). (B)
QPCR for importin family members in Klf6-silenced versus NT control primary mouse OLP, and O4+Apc+Mbp- iOL differentiated with T3 for 18 h. Note
that Klf6 control of Impα5 expression is selective. (C) Confocal imaging of lumbar spinal cords of E16.5Olig1Cre:Klf6fl/fl and Klf6fl/fl control embryos
(upper panels), andOlig1Cre:Stat3fl/fl and Stat3fl/fl control embryos (lower panels), showing reduced Impα5 expression in oligodendrocyte lineage cells in
mice with conditional Klf6 or Stat3 inactivation. Arrowheads in white matter areas (outlined) mark representative cells. Collectively, findings in (A–C) are
compatible with the hypothesis that gp130-driven Klf6 uses selective control of Impα5 to regulate oligodendrocyte development (D). (E–G) qPCR,
confocal imaging, and immunoblotting data from primary mouse OLP silenced for Impα5, then differentiated with T3 for 24–72 h. In (E), data for the myelin
marker Cnp are from 72 h; other data are from 24 h. Note that differentiation markers are strongly reduced in Impα5-silenced cultures at both the RNA (E)
and protein levels (F,G). See also S6F Fig. (H)OLP cultures from Klf6fl/flRosa26fl/fl mice were exposed to Ad5CMVCre or Ad5CMV control, then
nucleofected with either an Impα5 expression construct or empty vector. Cultures were treated with 40 ng/ml T3 and harvested at 72 h. Notably,
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the same origin as ventral OLP [27], and this resulted in perinatal lethality (Figs 5K and S6D).
These data suggested that Stat3 is required for both motor neuron and oligodendrocyte devel-
opment, while Klf6 is only necessary for oligodendrocyte development. To selectively test the
contribution to oligodendrocyte development, we examined the phenotype of PdgfracreERTM:
Stat3fl/fl mice, which undergo inducible recombination in OLP but not neurons [48]. Cre was
induced at E12.5, and embryos were harvested at E18.5. PdgfracreERTM:Stat3fl/fl embryos dis-
played no changes in Mnr+ neurons, but loss of differentiating oligodendrocytes and myelina-
tion deficits (Fig 5M).
Collectively, these data suggested that Klf6 and upstream gp130-Stat3 signaling are linked
and play essential roles in CNS myelination. Inactivation of either in oligodendrocytes results
in disruption of the other, associated with loss of differentiating oligodendrocytes and myelina-
tion failure.
Klf6 Promotes Differentiation via Transactivation of the Importin Effector
Impα5
Since our RNA-seq and ChIP-seq data identified direct Klf6 regulation of Impα5 (Fig 6A and
S3 Table), the major importin in the adult CNS [41], we hypothesized that the gp130-Klf6 axis
may use importins as important downstream effectors. Further analysis strongly suggested
that Klf6 regulates oligodendrocyte development in part via transactivation of Impα5 (Figs 6
and S6).
We initially tested whether Klf6 regulation of Impα5 is selective, using qPCR in Klf6-
silenced OLP, and iOL differentiated with T3 for 18 h (Fig 6B). The family of alpha importins
function by binding transcription factors at nuclear localization sequences (NLS), and associat-
ing with importin-β subunits to translocate through the nuclear pore [41]. These studies con-
firmed that Impα5 was downregulated in both Klf6-silenced OLP and iOL cultures, and
showed that other family members, including Impα1, Impα3, and Impβ1, were unaffected,
thus demonstrating selectivity (Fig 6B). Examination of Klf6-silenced cultures exposed to pro-
myelinating stimuli and treated with the caspase inhibitor Q-VD-OPh 2 μM confirmed that
loss of Impα5 in these cultures was not due simply to apoptotic loss of Impα5-expressing cells
(S6E Fig). Validating in vivo relevance, we detected reduced expression of Impα5 in the oligo-
dendrocyte lineage in spinal cords of mice with conditional Klf6 or Stat3 inactivation (Fig 6C).
Collectively, these findings were consistent with the hypothesis that the gp130-Klf6 axis uses
selective control of Impα5 as a downstream effector mechanism to regulate oligodendrocyte
development (Fig 6D).
Impα5 Is Required for Oligodendrocyte Viability and Differentiation
To test whether disruption of normal importin expression limits oligodendrocyte differentia-
tion and viability, we silenced Impα5 in primary cultures, then differentiated with T3 for 24–72
h, and analyzed via confocal imaging, immunoblotting, and qPCR. Notably, silencing of Impα5
produced a phenotype very similar to that seen following Stat3 or Klf6 inactivation, which was
further compatible with known roles for importins in differentiation and viability [41,42].
recombinant Impα5 significantly increased the proportion of cells expressing the differentiation marker O4. Recombinant Impα5 also partially rescued
differentiation in Klf6-deficient cultures. Numbers in panels (G,H) refer to proportion of cells positive for the maturation marker per field at 20x
magnification, for at least four fields per condition. Data are mean ± SEM. Statistics, (B,E,G) Student’s t test, (H) ANOVA plus Bonferroni post-test, *p <
0.05, ** p <0.01, *** p <0.001. Scalebars, (C,G,H) 20 μm. Data are representative of at least three independent studies. ChIP-seq data are available on
the GEOwebsite (http://www.ncbi.nlm.nih.gov/geo/) (Accession number GSE79245) and in S4 Table. Individual values for all other quantifications are in
S1 Data.
doi:10.1371/journal.pbio.1002467.g006
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Impα5 silencing resulted in strong inhibition of differentiation, as demonstrated by reduced
expression of myelin and maturation markers (Fig 6E–6G). Moreover, failure of differentiation
was also associated with apoptosis of differentiating cells (S6F Fig).
If Klf6 regulation of Impα5 is functionally important in the context of early OLP differenti-
ation, persistent expression of Impα5 might be expected to rescue, in part, the impact on dif-
ferentiation of Klf6 inactivation. To test this hypothesis, we used the viral vector Ad5CMVCre
to inactivate Klf6 in OLP cultures from Klf6fl/flRosa26fl/fl mice. We then nucleofected the
resulting Klf6-deficient cells and controls exposed to Ad5CMV control with either an Impα5
expression construct or empty vector. Cultures were then treated with 40 ng/ml T3, harvested
at 72 h, immunostained for the differentiation marker O4, and subjected to confocal imaging.
Tomato expression from the recombined Rosa26fl/fl locus was used to confirm Cre-mediated
recombination.
Notably, these experiments showed that expression of recombinant Impα5 in control OLP
significantly increased the proportion of cells expressing differentiation markers. Moreover,
and importantly, recombinant Impα5 partially rescued differentiation in Klf6-deficient cul-
tures (Fig 6H). Thus, these studies confirmed a functional role for Impα5 in OLP differentia-
tion, and suggested that it operates in the context of the gp130-Stat3-Klf6 axis.
Collectively, the findings of these experiments showed that importin activity is required for
oligodendrocyte differentiation and that Impα5 overexpression potentiates differentiation.
They further suggested that the gp130-Klf6 axis regulates oligodendrocyte development in part
via Impα5-based control of nuclear trafficking.
Discussion
This study identifies an essential role for the transcription factor Klf6 in CNS myelination and
shows that it acts as a control point through which a pro-myelinating signal regulates oligoden-
drocyte development. Extrinsic cues are important regulators of CNS myelination [5], but the
mechanisms by which they regulate viability, proliferation, and differentiation are incompletely
characterized. Our findings place Klf6 within a novel axis driven by upstream gp130-Stat3 sig-
naling, previously implicated as promoting survival and maturation in oligodendrocytes and
other lineages [7,10,11,31,32]. Our data show that gp130/Stat3-driven Klf6 induction promotes
differentiation, whereas mice with lineage-selective inactivation of Klf6 or upstream Stat3 sig-
naling show profound failure of CNS myelination, which results in tremor, ataxia, and death.
Lineage specification and OLP proliferation and migration remain intact in these mice. The
earliest events in differentiation occur normally, but subsequent steps in differentiation to the
iOL stage are delayed, and terminal maturation fails and is associated with apoptosis. Compati-
ble with the precedent set by gp130-Stat3 signaling, our studies further suggest that Klf6 plays
distinct roles in both differentiation and viability. Pharmacologic inhibition of apoptosis in
Klf6-deficient cultures does not restore differentiation. Interestingly, these findings contrast
sharply with the lack of detectable developmental impact of inactivation of astrocytic Klf6 in
mice using anmGfapCre cassette, despite the fact that gp130 signaling is known to be impor-
tant in astrocyte development and response to injury [49–51].
Members of the Klf/Sp transcription factor family fulfill diverse functions, in roles that are
lineage- and time-dependent [13,52]. Our findings improve our understanding of their contri-
butions to CNS development and molecular mechanisms of action. Klf6 has previously been
studied as a tumor suppressor in prostate, ovary, and liver [18], and Klf4, Klf5, and Klf6 are
also implicated as regulators of viability [13]. Our data now reveal that in the CNS, Klf6
regulates oligodendrocyte development and is driven by gp130-Stat3 signaling. This work fur-
ther implicates the nuclear import protein Impα5 as an important, directly regulated Klf6
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downstream effector. Interestingly, analysis of an external published RNA-seq database also
reveals similar expression profiles for gp130, Stat3, Klf6, and Impα5, which in that dataset all
progressively decrease during oligodendrocyte differentiation [29]. While our in vitro data
suggest a critical requirement for gp130-Klf6-Impα5 signaling in early differentiation, the
decreased activity of the axis in mature oligodendrocytes likely indicates a less critical role in
maintenance of the mature, myelin-forming cell. It is possible that other members of both fam-
ilies may take over those roles following maturation.
While selective inactivation of importins is known to result in compensatory upregulation
of other family members [42], our studies suggest that disruption of Impα5 is sufficient to dis-
rupt differentiation and viability. Furthermore, recombinant Impα5 expression significantly
increases the number of differentiated cells in OLP cultures, and, importantly, recombinant
Impα5 partially rescues differentiation in Klf6-deficient cultures. Cell-type-specific interactions
between Klf family members and importins have only recently been identified [53]. Our data
suggest that such an interaction, Klf6 transactivation of Impα5, may represent an important
mechanism regulating oligodendrocyte survival and maturation, which is, moreover, sensitive
to and feeds back upon an extrinsic gp130-mediated pro-myelinating signal. Importin canoni-
cal functions are to shuttle larger-sized cargo into the nucleus, with smaller factors entering
passively through the nuclear pore complex [43]. Thus, we might expect various factors neces-
sary for OLP differentiation to be size-selectively dependent on or independent of the Klf-
importin axis. Accounting for the full range of importin regulation of transcription factor traf-
ficking in oligodendrocytes will require co-immunoprecipitation and mass spectrometry analy-
ses, with functional validation. While beyond the scope of the current report, such studies
may produce a more complete understanding of the mechanisms regulating oligodendrocyte
development.
Interestingly, while our data show that upstream gp130-Stat3 signaling drives Klf6 regula-
tion of oligodendrocyte development, we also identify multiple components of the gp130 path-
way as Klf6-regulated. Thus, our data suggest Klf6 participates in positive feedback regulation
of a pro-myelinating pathway that drives its own expression. Furthermore, lineage-specific
inactivation of Stat3 produces a phenotype resembling conditional Klf6 inactivation, including
myelination failure, which is further associated with disruption of Klf6 and Impα5 expression,
or loss of expressing cells within the oligodendrocyte lineage. Thus, our study validates Stat3
signaling as required for CNS myelination, and establishes Klf6 as a link between the upstream
gp130-Stat3 pathway and a downstream importin effector. A secondary finding from our work
also confirms the significance of Stat3 signaling in spinal cord motor neuron development,
consistent with previous data [54]. This suggests a lineage-specific difference in neuronal ver-
sus oligodendrocyte development. We speculate that the role of Klf6 in oligodendrocytes may
be filled in neurons by a different family member.
While Klf6 alone is not capable of initiating differentiation in our studies, its overexpression
accelerates the rate of differentiation, as does Impα5 overexpression. Moreover, a basal level of
each is required for differentiation, regardless of the triggering stimulus. Thus, these data sug-
gest that the Klf6–Impα5 axis likely represents a component within the differentiation pro-
gram, as opposed to an adaptor mechanism used by an extrinsic pro-myelinating signal. It is
intriguing to speculate whether this mechanism may integrate more than one extrinsic input to
the differentiation program, or whether it is specific for the gp130 pathway. Perhaps suggesting
the latter, our data show that while Cntf readily activates the pathway, in contrast, T3 has no
effect and, moreover, does not produce compensatory induction in the absence of a functional
gp130-Stat3 pathway. Further studies are indicated to test whether Klf6 actions in oligodendro-
cyte development are under the control of just one pro-myelinating cue, or whether they may
represent a point of convergence for additional extrinsic inputs.
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In summary, our results connect an essential role for gp130/Stat3 signaling in CNS myelina-
tion, with importin-based control of nuclear trafficking as a downstream effector mechanism.
Most notably, our findings implicate Klf6 as coordinating these events. Thus, our data reveal
regulation of Klf6 as a mechanism via which an extrinsic signal promotes oligodendrocyte
development and CNS myelination. Reconstructing early developmental processes responsible
for the initiation and refinement of myelin formation may contribute to our understanding of
the pathophysiology of neonatal, infantile, and pediatric leukoencephalopathies. Further stud-
ies will also determine whether reactivation of the gp130-Klf6 axis plays a significant role in
promoting re-myelination in adults, in normal myelin turnover, or after injury, with the latter
having implications for demyelinating disorders such as multiple sclerosis.
Materials and Methods
Mice
Work was approved by Institutional Animal Care and Use Committee at the Icahn School of
Medicine at Mount Sinai under protocol numbers LA13-00029 and LA12-00235 and adhered
to the American Veterinary Medical Association guidelines. Our institution has an Animal
Welfare Assurance on file with the Office for Laboratory Animal Welfare. The Assurance num-
ber is A3111-01. Olig1Cremice were generated by Q. Richard Lu, Charles Stiles (Harvard
University, Massachusetts), and David Rowitch (University of California, San Francisco, Cali-
fornia) [27]. Klf6fl mice were generated and provided by Fréderic de Sauvage (Genentech,
South San Francisco, California) and give a deletion/hypomorphic phenotype upon Cre recom-
bination [26]. Stat3fl mice were generated and provided by Shizuo Akira [47]. NG2creERTM
mice were generated by Akiko Nishiyama [30] and purchased from Jackson Laboratories (Bar
Harbor, Maine). PdgfracreERTM mice were generated and provided by Dwight Bergles [48].
mGfapCremice were generated and provided by Michael V. Sofroniew (University of Califor-
nia Los Angeles) [28]. Rosa26CAG-tdTomato mice were purchased from Jackson Laboratories (Bar
Harbor, Maine). Genotyping was performed by PCR using primers in S6 Table. Conditional
ablation of Klf6 or Stat3 in OLP in NG2creERTM or PdgfracreERTM embryos was induced by
administration of 4-OH-tamoxifen (10 mg/mL) to pregnant mice at E12.5 and harvesting at
E18.5 by euthanizing mothers with CO2 from compressed gas plus cervical dislocation, with
the embryos removed by caesarean section and immediate decapitation prior to fixation. In the
breeding programs for all mice, a strict set of humane endpoints was in place. Any mouse
reaching any of these endpoints was immediately given an anesthetic overdose (barbiturate, 60
mg/kg ip), then received cardiac perfusion with either 4% paraformaldehyde or 4% glutaralde-
hyde for collection of tissue samples. Humane endpoints were: (1) weakness or paralysis such
that the animal was unable to obtain food/water, (2) tremor severe enough to render the animal
unable to move around the cage freely, (3) head tile or head turn associated with circling (ani-
mal unable to move freely), (4) depression/reduced level of activity to the point of failure to
ingest food/water, (5) significant weight loss (>20% of body weight) associated with failure to
eat/drink, (6) any other sign that the animal was unable to thrive in its environment. In addi-
tion, any animal showing any other complications (such as swelling, discharge, or pyrexia
indicative of infection) was euthanized immediately using an anesthetic overdose. Mice were
inspected at least once daily. In the initial breeding program for Olig1Cre:Klf6fl/fl mice, we
detected ataxia/tremor in the experimental genotype from 10 d of age. Additionally, one to two
pups of the experimental genotype in the initial cohort died unexpectedly from a single grand
mal seizure lasting 1–2 s. Once these phenotypes were detected, final breedings were subse-
quently planned such that mice were sacrificed prior to risk of suffering or mortality. In the
breeding program for Olig1Cre:Stat3fl/fl mice, in initial litters resulting from final matings, we
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detected pups of the experimental genotype dead immediately following birth. Thereafter, we
used only developmental studies to characterize this line.
OLP Cultures
Mouse OLP were isolated from P6-P7 C57BL6 mice and cultured as previously described [55].
Briefly, after removal of olfactory bulbs, brainstem, hippocampus, and meninges, cerebral cor-
tices were isolated, dissociated, and resuspended in panning buffer. Single-cell suspensions
were sequentially panned: twice on BSL1 plates for microglia depletion (15 min each), and
then once on PDGFRa (CD140a, BD Bioscience) plates (45 min), and adherent cells were tryp-
sinized and plated onto poly-D-lysine coated confocal dishes (Mat-Tek, Ashland, Massachu-
setts) in the proliferative factors PDGF-AA (10 ng/ml) and bFGF (20 ng/ml). After 24 h, cells
were plated into differentiation medium containing 100 ng/ml Cntf or 40 ng/ml T3, or other
factors or pharmacologic agents as specified in the text, and grown for up to 4 d. At plating,
these cultures are>95% Olig2+Pdgfrα+Ng2+Cnp-Mbp-OLP. The immortalized cell line, Oli-
neu [24], was grown in Sato medium + 1% horse serum (HS) and differentiated by withdrawal
of HS for 24 h followed by the addition of T3 or Cntf at above concentrations.
Growth Factors
PDGF-AA, bFGF, Lif, T3, and Cntf were purchased from Peprotech (Rocky Hill, New Jersey)
and used at concentrations identified in the text.
Inhibitors
The caspase inhibitor Q-VD-OPh and Jak inhibitor CAS457081-03-7 were obtained from
EMD Bioscience and used at concentrations described in the text. For all experiments, growth
factors were added on top of inhibitors, maintaining described concentrations.
Transfection
For siRNA studies, 2.6 μg specific or nontargeting siRNA was nucleofected into OLP via elec-
troporation using the Amaxa Basic Primary Neuron Nucleofector Kit (Lonza Cologne GmbH,
Köln, Germany), protocol O-005, according to the manufacturer's instructions. In pilot studies
for siKlf6, multiple siRNAs were used, corresponding to different regions of the target RNA,
and specificity and efficiency were compared. The primary siRNA used to target Klf6 mRNA
was J-043530-09 (GCAGGAAAGUUUACACGAA). Two additional siRNAs were used to
assess specificity (J-043530-10: CUACAGAUUGUGCACGAAA; J-043530-12: GGACGAA
UCCUGUAGGCUA). All other siRNA used in the text were ON-TARGETplus mouse siR-
NA-Smart Pool (GE Healthcare Dharmacon, Lafayette, Colorado) comprising four different
siRNA targeting regions throughout specific genes of interest. Sham (transfection reagent
alone) was used as an additional control. Extent and specificity of silencing were assessed by
qPCR and immunoblotting. For expression constructs in OLP, cells were transfected using
Amaxa Basic Primary Neuron Nucleofector Kit (Lonza Cologne GmbH, Köln, Germany),
protocol O-005, with 1 μg expression vector pCMV6-AC-GFP containing GFP tagged Klf6,
pCMV6-Entry containing Myc-DDK tagged Kpna1, or empty vector-GFP/DDK control
(Origene, Rockville, Maryland). Expression was confirmed by immunostaining and confocal
microscopy.
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Adenoviral Transfer In Vitro
OLP cultures from Klf6fl/flRosa26fl/flmice were performed as described above. Following expan-
sion in proliferating media, OLPs were treated with either Ad5CMV-eGFP, for empty vector
controls, or Ad5CMVCre-eGFP (Gene Vector Core, University of Iowa) to initiate Cre recom-
bination (m.o.i = 22.5). After 4 h, cells were washed once in DMEM, nucleofected with Impα5
expression constructs or empty vector control as above, and incubated for 24 h in proliferating
media prior to differentiation. Cells were counted the night prior to virus treatment to estimate
m.o.i.
Antibodies
Apc/CC-1 (mouse: Abcam, Cambridge, Massachusetts); β-actin (mouse: Santa Cruz Biotech-
nology, Santa Cruz, California); BrdU (chicken: Immunology Consultants, Newberg, Oregon;
mouse: AbD Serotec, Raleigh, North Carolina); Cleaved caspase-3 (rabbit: Cell Signaling, Dan-
vers, Massachusetts); Cnpase (mouse: Covance, Princeton, New Jersey); Gfap (rat: Life Tech-
nologies, Carlsbad, CA); GFP (chicken: Abcam, Cambridge, Massachusetts); Ki-67 (rabbit:
Abcam, Cambridge, Massachusetts); Klf6 (mouse monocloncal, rabbit polyclonal: Santa Cruz
Biotechnology, Santa Cruz, California; rabbit: LifeSpan Biosciences Inc, Seattle, Washington);
Impα5 (rabbit: Proteintech, Chicago, Illinois), Mag (rabbit: Dr. Jim Salzer, New York Univer-
sity, New York); Mbp (mouse: Covance, Princeton, New Jersey; rabbit: Abcam, Cambridge,
Massachusetts; rat: Millipore, Billerica, Massachusetts); Mnr2 (rabbit: Developmental Hybrid-
oma Studies Bank, University of Iowa); NeuN (mouse: Millipore, Billerica, Massachusetts);
Ng2/Cspg4 (rabbit: Developmental Hybridoma Studies Bank, University of Iowa); Nkx2.2
(mouse: Developmental Hybridoma Studies Bank, University of Iowa); O4 (mouse: Dr. Peter
Davies, Albert Einstein College of Medicine, Bronx, New York); Olig2 (mouse, rabbit: Milli-
pore, Billerica, Massachusetts); Pdgfrα (rabbit: Cell Signaling, Danvers, Massachusetts); Sox9
(rabbit: Millipore, Billerica, Massachusetts); Stat3 (rabbit, mouse: Cell Signaling, Danvers, Mas-
sachusetts); Stat3-p-Y705 (rabbit: Cell Signaling, Danvers, Massachusetts). Rabbit, mouse, goat
IgG-HRP from Santa Cruz Biotechnologies, Santa Cruz, California. Secondary antibodies for
immunofluorescence were conjugated to AlexaFluor 488, AlexaFluor568, or AlexaFluor 647
(Life Technologies, Carlsbad, California).
Immunocytochemistry
Cultures were fixed with 4% paraformaldehyde for 10 min, rinsed three times with PBS, then
incubated in blocking buffer (10% normal goat or donkey serum in PBS/Triton 0.3%) for 1 h at
room temperature. Cells were incubated with primary antibodies for markers as specified in
the text diluted in blocking buffer overnight at 4°C. For surface antigen staining, cells were
blocked with 10% goat serum in PBS for 30 min and incubated with primary antibody. After
rinsing three times with PBS/Triton 0.3%, samples were incubated with appropriate AlexaFluor
conjugated secondary antibody, diluted 1:100 in blocking buffer for 1 h at room temperature.
Following rinsing, cells were mounted using DAPI Fluoromount-G (SouthernBiotech, Bir-
minhgam, Alabama) and photographed using a Leica Microsystems inverted confocal
microscope (Buffalo Grove, Illinois) or Zeiss LSM 880 inverted confocal microscope (Jena,
Germany). To assess proliferation, 10 μM BrdU (BD, San Diego, California) was added to cells
24 h prior to fixation. To assess apoptosis, immunohistochemistry using an antibody against
cleaved caspase-3 was performed. To assess cell cycle exit, an index previously described [56]
assessing the proportion of Ki67-BrdU+ cells to the total population of BrdU+ cells was used.
Cells positive for all markers were quantified in Z-series stacks collected at x20 magnification
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with 1 μm on the Z-axis. Cells were counted in at least five stacks per condition per marker per
time point in each experiment by a blinded observer using ImageJ software.
Immunoblotting
Protein extracts were separated by sodium dodecyl sulfate-polacrylamide gel electrophoresis
(SDS-PAGE) and transferred to onto PVDF membranes (Miliipore, Billerica, Massachusetts)
using a buffer containing 25 mM Tris base, pH 8.3, 192 mM glycine, 20% (vol/vol) methanol
for 1 h at 100 V at 4°C. Membranes were blocked for 1 h in 10% milk/0.1% Tween/TBS, then
incubated overnight at 4°C with primary antibodies as described in the text. After incubation
in primary antibody, membranes were rinsed with 0.1% Tween/TBS three times and subse-
quently incubated for 2 h at room temperature with secondary light-chain specific HRP-conju-
gated antibodies diluted 1:1000 in 10% milk/0.1% Tween/TBS. After rinsing, membranes
were incubated with ECL (Thermo Scientific, Somerset, New Jersey) for 10 min and then
revealed. For densitometry, unsaturated films were scanned using a Canon LiDE scanner (Lake
Success, New York) and mean pixel density of each band measured using ImageJ software.
Measurements were standardized to actin loading control, and fold change versus control was
calculated.
Immunohistochemistry
Frozen 25 μm sections of paraformaldehyde-perfused CNS were immunostained as described
above and previously [57]. The following pre-treatments were used prior to blocking; for Mbp
(SMI-99) or Stat3, sections were rinsed once in PBS, then incubated in 100% methanol at
-20°C for 10 min and washed three time with PBS; for all other immunostainings, sections
were soaked in 100°C citrate buffer pH 6 for 15 min, then let to cool in the buffer to room tem-
perature and washed three time in PBS. Samples were then incubated in blocking buffer (10%
normal goat or donkey serum in PBS/Triton 0.3%) for 1 h at room temperature. Cells were
incubated with primary antibodies for markers as specified in the text and diluted in blocking
buffer overnight at 4°C. After rinsing three times with PBS/Triton 0.3%, samples were incu-
bated with appropriate AlexaFluor conjugated secondary antibody and diluted 1:100 in block-
ing buffer for 1 h at room temperature. Following rinsing, cells were mounted using DAPI
Fluoromount-G (SouthernBiotech, Birminhgam, Alabama). Immunofluorescent stains for
Klf6, Impα5, and Pdgfrα in embryonic and P1 tissue were accomplished via a signal amplifica-
tion protocol (Perkin Elmer). Samples were examined using a Leica DMI or Zeiss LSM880 con-
focal microscope, and stacks were collected using 1–2 μm on the Z-axis and assembled into
projections. For assessment of proliferation, mice received 10 mg/kg BrdU injection 1 h before
fixation. To assess apoptosis, immunohistochemistry using an antibody against cleaved cas-
pase-3 was performed. Cross-sectional Mbp+ or NeuN+ area and number of cells positive for
lineage or stage-specific markers were measured in each stack using ImageJ software (NIH) by
a blinded observer. For analyses of spinal cord, lumbar sections were analyzed and patterns
confirmed in thoracic sections. Total Mbp+ or NeuN+ area per section was measured, or total
number of positive cells per section counted, in the number of mice per genotype per time
point stated in each figure legend. For other regions of the CNS (cerebellum, corpus callosum),
positive area was measured (for Mbp and NeuN) or number of cells counted in at least 5 fields
at 20x magnification per animal, in the number of mice per genotype per time point stated.
Histopathology
Epoxy-embedded sections of glutaraldehyde-perfused corpus callosum, cerebellum, lumbar
spinal cord, and optic nerve (1 μm) were stained with toluidine blue and photographed on a
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Zeiss Axioplan2 microscope. For electron microscopy, serial sections were placed on 200 mesh
copper grids, contrasted with lead citrate and uranyl acetate, and scanned in a Hitachi HS600
microscope (Hitachi Inc., Pleasanton, California, at least five fields per animal, at least four
mice per genotype per time point). For measurement of myelin thickness and G ratio, axon
and fiber diameter were measured in at least ten random axons per field (at least five fields per
condition) by a blinded observer using ImageJ. Myelin thickness was defined as (fiber diameter
—axon diameter)/2, and G ratio as (axon diameter)/(fiber diameter).
RNA Isolation and qPCR Analysis
RNA was isolated from cultures using the RNeasy Mini kit (QIAGEN) and quality was assessed
using a Nanodrop spectrophotometer (Wilmington, Delaware). RNA was used in a 20 μl
reverse transcription reaction, using SuperScript RT-PCR kit (Invitrogen). qPCR was per-
formed using PerfeCTa SYBR Green FastMix (Quanta Biosciences) and an Applied Biosystem
7900HT Sequence Detection PCR System. The melting curve of each sample was measured to
ensure product specificity. Data were normalized to internal controls Actin/Gapdh/Rps11 and
analyzed using the Pfaffl ΔΔCt method. Primers for qPCR are presented in S6 Table.
BeadArray
CNS (brain and spinal cord) of experimental Olig1Cre:Klf6fl/fl mice and sex-matched Klf6fl/fl lit-
termate controls at postnatal day 1 (five per group per experiment) were dissected and snap
frozen, total RNA was extracted using the RNeasy Mini kit (Qiagen), and quality was assessed
by Nanodrop spectrophotometer. Total RNA was converted to cDNA and subsequently to
biotin-labeled cRNA using a commercially available kit (Illumina, San Diego, California)
according to the manufacturer’s instructions, and 1.5 μg of cRNA was hybridized to Illumina
MouseWG-6 v1.1 expression BeadArray of 45,200 cDNA probes. Raw expression data were
subjected to quantile normalization and low-intensity value filtering using a cutoff of 200 and
then were log2 transformed (MatLab, MathWorks, Natick, Massachusetts). Differentially
expressed genes were identified using unpaired two-tailed t test with False Discovery Rate
(FDR) correction p< 0.05. Qualifying genes were subjected to hierarchical clustering using
Cluster 3.0 software (Michael Eisen, UC Berkeley), and converted to a colorimetric format
using Java Treeview (Alok Saldanha, Open Source Clustering Software). Data are available on
the GEO website (http://www.ncbi.nlm.nih.gov/geo/) (Accession number GSE79245).
ChIP and ChIP-seq Analysis
Chromatin was isolated from OLP and early iOL (4×106 cells per sample). Cells were cross-
linked in 1% formaldehyde for 7 min, and nuclear extraction and lysis were subsequently per-
formed using sequential cell lysis (HEPES 5 mM pH8, KCl 85 mM, NP 40 0.5%, Protease
Inhibitors [Sigma], PMSF 1 mM) and nuclear lysis buffer (50 mM Tris-HCl pH 8.1, 10 mM
EDTA, 1% SDS, Protease Inhibitors [Sigma], PMSF 1 mM). Chromatin was sonicated using a
Bioruptor (Diagenode) sonicator to produce chromatin with an average length of 200–400
base pairs. The size of DNA in the sheared chromatin fragments was tested by gel electrophore-
sis and Bioanalyzer to ensure proper fragment size. Immunoprecipitation was performed with
2 μg of anti-Klf6 antibody (polyclonal rabbit anti-Klf6, Santa Cruz, Santa Cruz, California) per
unit OD260 readings. A total of four units of chromatin were used per condition. The DNA
recovered from chromatin that was not immunoprecipitated was used as input. Chromatin
that was immunoprecipitated with pre-blocked Staph A cells (Millipore, Billerica, Massachu-
setts) in the absence of primary antibody was used as a negative control. Following immuno-
precipitation overnight, chromatin was incubated with Staph A cells for 14 min at room
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temperature, and samples were washed twice in Dialysis Buffer (2 mM EDTA, 50 mM Tris-
HCl pH 8.0, 0.2% Sarkosyl) and four times in IP wash buffer (Tris-HCl 100 mM, pH 9.0, LiCl
500 mM, NP40 1%, Protease inhibitors, PMSF 1 mM) modified for polyclonal antibodies.
Immunoprecipitated chromatin and input DNA were reverse crosslinked in elution buffer (50
mMNaHCO3, SDS 1%) with the addition of NaCl 0.2 M by heating at 67°C and shaking at
1300 rpm using a thermomixer (Eppendorf) overnight. DNA was then purified from the elu-
tion using phenol-chloroform-isoamylalcohol followed by an overnight ethanol precipitation
at -20°C.
The input and ChIP samples were sequenced by Illumina HiSeq 2000. ChIP-seq was per-
formed with two biological replicates per condition. Read sequences were generated by analyz-
ing images and base calling using Illumina data analysis pipeline. After QC filtering by FASTX
(http://hannonlab.cshl.edu/fastx_toolkit/), only reads with a quality score Q20 in at least 90%
of bases were included for analysis. Reads from both input and ChIP samples were aligned to
mouse reference genome (mm9) using Bowtie2 [58]. The peaks in the ChIP sample in reference
to the input sample in OLP and iOLs were called from read alignments by MACS algorithm
[59], then annotated with gene information, including distance to TSS and locations in gene
function elements (intron, exon, UTR, upstream or downstream) from genome mapping infor-
mation of RefSeq transcripts. Peaks within an interval of −15 kb to +5 kb to TSS of annotated
genes were compared, and peaks with a maximum gap of 500 bp were considered overlapped.
Alignment and coverage of ChIP-Seq data were visualized using Integrative Genomics Viewer
(IGV) software [60], after input subtraction using methods described previously [61]. FDR-
adjusted p-values of<0.05 were deemed significant. Data are available on the GEO website
(http://www.ncbi.nlm.nih.gov/geo/) (Accession number GSE79245).
RNA-seq Analysis
250ng of total RNA per sample were isolated from duplicate independent cultures of OLP, and
early iOL after 18h of differentiation using the RNeasy Mini kit (QIAGEN). Libraries were
constructed using the TruSeq RNA Sample Prep Kit (Illumina), and sequenced using an Illu-
mina HiSeq 2000. Output files were subjected to quality control using FASTQC (http://www.
bioinformatics.babraham.ac.uk/projects/fastqc/). All reported metrics including read quality
score, adapter sequence contamination, and nucleotide frequency bias passed the suggested
thresholds for all samples. Reads were analyzed using the Tuxedo suite [62], using the standard
suggested pipeline with default parameters. Adapter-trimmed reads were mapped to the mouse
genome (mm9) using Tophat. Transcript quantification was performed using CuffLinks [63],
with expression normalized using CuffNorm and differential gene expression assessed with
CuffDiff. FDR-adjusted p-values of<0.05 were deemed significant. RNA-seq data are available
on the GEO website (http://www.ncbi.nlm.nih.gov/geo/) (Accession number GSE79245).
Gene Ontology
Analysis to identify physiologic functions or diseases most relevant to sets of differentially
expressed genes in RNA-seq and microarray studies was carried out using Ingenuity software
(Ingenuity Systems, Redwood City, California), which uses Fisher’s exact test to calculate a p-
value that the association between biological functions and a set of genes is due to chance alone.
Statistics
For multiple comparisons, ANOVA plus Bonferroni post-test was used. Comparisons between
two groups used Student's t test. In BeadArray studies, data were compared using unpaired
two-tailed t test with False Discovery Rate correction. p< 0.05 was considered significant.
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Supporting Information
S1 ARRIVE Checklist. ARRIVE guidelines checklist for reporting in vivo experiments.
(PDF)
S1 Data. Individual values used for quantitation in the text, figures, and supplementary
materials.
(XLSX)
S1 Fig. Construction and technical validation of Klf6 conditional knockout lines.Data pre-
sented here support findings in Fig 1. (A)QPCR analysis of Klf6 responses to the pro-myelinat-
ing factors Cntf (100 ng/ml), Lif (100 ng/ml), and T3 (40 ng/ml) in Oli-neu cells. Data extend
results in Fig 1B. (B) To inactivate Klf6 in oligodendrocyte lineage cells or astrocytes in
vivo, mice with loxP sites flanking Klf6 exons 2 and 3 (Klf6fl) were crossed with Olig1Cre or
mGfapCre lines. The DNA constructs for each allele are illustrated in this panel. (C) Results of
PCR genotyping of lines produced by crossing the alleles shown in panel (B). In both lines,
final matings generate the experimental and three control genotypes each at approximately
25% of total. (D) Confocal images of P14 spinal cords of Olig1Cre:Klf6fl/fl andmGfapCre:Klf6fl/fl
mice and Klf6fl/fl controls. Specificity and efficiency of inactivation in each line are confirmed
by confocal imaging for lineage markers. The percentage of cells in each lineage that are Klf6+
is shown. In controls, Klf6 localizes to nuclei of oligodendrocytes and neurons and Gfap+ astro-
cytes (see Fig 1E). The upper four panels show that Klf6 and Olig2 overlap in oligodendrocyte
lineage nuclei in Klf6fl/fl controls, whereas Olig2+ cells in Olig1Cre:Klf6fl/fl samples are Klf6 neg-
ative. Demonstrating specificity of inactivation, NeuN+ neurons (lower motor neurons illus-
trated) are Klf6 positive in both genotypes. The lower four panels demonstrate that conversely,
inmGfapCre:Klf6fl/fl samples, Klf6 is selectively lost from nuclei of Gfap+ astrocytes, but not
from Olig2+ oligodendrocyte lineage cells. Data shown are representative of at least three inde-
pendent studies in separate cultures (A), or from at least three pups per genotype (C,D).
Data in panel (D) are presented as mean +/- SEM. Scalebars, (D) 5μm. Individual values are in
S1 Data.
(TIF)
S2 Fig. Myelination failure in Olig1Cre:Klf6fl/fl spinal cord. Data shown complement results
in Fig 1. (A–D) Confocal imaging analysis of lumbar spinal cords of P14 Olig1Cre:Klf6fl/fl mice,
mGfapCre:Klf6fl/fl mice, and Klf6fl/fl controls. Areas outlined in (A) are shown at higher magni-
fication, inset. In contrast to controls and samples from mice with astrocyte-selective inactiva-
tion, myelin proteins are almost completely absent from spinal cords of Olig1Cre:Klf6fl/fl mice
(A,B). Immunoreactivity for myelin proteins is normal in peripheral nerve roots (A, arrowed).
No differences are seen in either genotype in expression patterns of the astrocyte marker
Gfap or numbers of NeuN+ neurons (C,D). (E–H) Light microscopy of resin-embedded P14
Olig1Cre:Klf6fl/fl and Klf6fl/fl spinal cord stained with toluidine blue. Areas 1–3 outlined in (E)
are shown at increased magnification in (F–G), and panel (G) is shown at high magnification
in (H). Myelin sheaths are almost completely absent from Olig1Cre:Klf6fl/fl white matter tracts,
and almost no small cells with round nuclei characteristic of oligodendrocytes are present. In
(F), compare unmyelinated Olig1Cre:Klf6fl/fl CNS white matter (“c”) with normally myelinated
peripheral nerve roots (“p”) in the same samples. (I–K) Electron micrographs of P14 (I,J) and
P19 (K) Olig1Cre:Klf6fl/fl and Klf6fl/fl spinal cords, with higher magnification images inset. In
contrast to compact myelin observed in controls (for example, I, left panel and inset), almost
no myelin sheaths are present in Olig1Cre:Klf6fl/fl CNS samples at P14 (I, right panel and inset,
J) or closer to death at P19 (K). No axonal pathology or degeneration is seen at either time
point. Peripheral nerve roots of Olig1Cre:Klf6fl/fl mice are normally myelinated (J). Confocal
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imaging data shown are from lumbar sections of two to four mice per genotype. Thoracic sec-
tions showed the same findings. Electron microscopy data from P14 are representative of
three mice per genotype, electron microscopy data from P19 are from two mice per genotype
due to scarcity of samples and matched findings from P14 samples. Results are presented as
mean ± SEM. Statistics, (B,D) ANOVA plus Bonferroni test, p< 0.001. Scalebars, (A,C)
main panels 150 μm, (A) inset 15 μm. Magnifications, (E) x10, (F,G) x500, (H) x1000, (I,K)
x5,000, inset x20,000, (J) x3,000. Individual values are in S1 Data.
(TIF)
S3 Fig. Failure of myelination throughout the CNS in Olig1Cre:Klf6fl/fl mice. Results are
complementary to and extend data in Fig 1. (A–F) Analysis of P14 Olig1Cre:Klf6fl/fl,mGfapCre:
Klf6fl/fl, and control Klf6fl/fl cerebellum and corpus callosum. In contrast to results from the
other two genotypes, myelin markers are almost completely absent from cerebellar white mat-
ter (A,B) and corpus callosum (C,D) in Olig1Cre:Klf6fl/fl samples, and both tracts are thinner
than normal (A,C, arrowheads). No changes are seen in neuronal numbers (E,F). (G–I) Light
and electron microscopy of P14 cerebellum (G) and optic nerves (H,I) from Olig1Cre:Klf6fl/fl
and Klf6fl/fl control mice. In (G), the area outlined in the upper panel is shown at higher magni-
fication, below. Both tracts are unmyelinated in Olig1Cre:Klf6fl/fl mice. In the lower panel, a
rare myelinated fiber found in an Olig1Cre:Klf6fl/fl sample is arrowed. Granule and Purkinje
neurons in adjacent cerebellar grey matter are normal. Data shown are from two to four mice
per genotype (for confocal imaging data) or three mice per genotype (for light/electron micros-
copy data). Quantitative data are presented as mean ± SEM. Statistics, (B,D,E,F) ANOVA plus
Bonferroni test, p< 0.01,  p< 0.001. Scalebars, (A,C) 100 μm. Magnifications, (G) upper
panel x500, lower x1,200, (H) x600, (I) x2,000. Individual values are in S1 Data.
(TIF)
S4 Fig. Klf6 inactivation in OLP using different Cre drivers produces convergent pheno-
types. Results extend and complement findings shown in Figs 1, 2 and 3. (A) BeadArray
transcriptional analysis of total CNS of P1 Olig1Cre:Klf6fl/fl pups and sex-matched Klf6fl/fl litter-
mates, five per group. These data were used to generate the Ingenuity gene ontology analysis
presented in Fig 1M. Data have been normalized and log2 transformed, and differentially
expressed transcripts identified using unpaired two-tailed t test with False Discovery Rate cor-
rection. All transcripts with significant FDR-corrected p-values (Q values)<0.05 are shown.
Results have been subjected to hierarchical clustering and are presented as numbered clusters
in colorimetric format. There are significant differences in 60 probes corresponding to 51
annotated transcripts, all but one of which are reduced in Olig1Cre:Klf6fl/fl CNS. Of these, 24
correspond to 18 genes previously reported as oligodendrocyte-expressed, shown in blue text.
There are no changes in markers of neurons, astrocytes, or inflammatory cells. Note that tran-
scriptional profiling of entire CNS data does not distinguish between changes in expression in
living cells, versus loss of the cells that normally express the transcript. (B) Results of confocal
imaging analysis comparing Olig2+ cell number in P14 spinal cords of Olig1Cre:Klf6fl/fl condi-
tional knockout mice, Olig1Cre:Klf6fl/+ heterozygotes and Klf6fl/fl and Klf6fl/+ controls. Data
complement Fig 2A–2D. While Olig2+ cell numbers are severely reduced in Olig1Cre:Klf6fl/fl
mice, numbers in heterozygotes are normal, matching those in controls. (C,D) Confocal and
morphometric analysis of spinal cords of E18.5 NG2creERTM:Klf6fl/fl embryos, in which Klf6
inactivation has been inducibly targeted to OLP. See also Fig 2M. (C) Similar to results from
Olig1Cre:Klf6fl/fl mice, NG2creERTM:Klf6fl/fl mice display selective loss of differentiating
oligodendrocytes. In contrast, and again similar to Olig1Cre:Klf6fl/fl mice, OLP numbers in
NG2creERTM:Klf6fl/fl embryos are identical to controls (D). (E) qPCR in Oli-neu cells treated
with 100 ng/ml Cntf or 40 ng/ml T3. Both produce comparable rates of differentiation as
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measured by expression of myelin proteins (Cnpase) and downregulation of OLP markers
(Pdgfrα). In Cntf- but not T3-treated cultures, Klf6 upregulation precedes differentiation. (F)
Densitometry measurements of immunoblotting data for Klf6, Cnpase, and Pdgfrα in primary
mouse OLP differentiated with T3 and harvested at 24 h intervals. Actin was used as a loading
control. Klf6 expression decreases during differentiation, preceding loss of the OLP marker
Pdgfrα and upregulation of the myelin protein Cnpase. (G) Findings from primary OLP cul-
tures in which Klf6 has been silenced using siRNAs specific for different regions of its mRNA
sequence (right panel). Sequence 1 corresponds to the siRNA used in the remainder of the
manuscript. Cultures have been treated with Cntf 100 ng/ml for 2 h, then RNA harvested for
qPCR. These findings complement Fig 3A–3H. Data are presented as mean ± SEM. Statistics,
(A) unpaired two-tailed t test with False Discovery Rate correction, (B) one-way ANOVA
plus Bonferroni test, (C,D) Student’s t test, (E) two-way ANOVA plus Bonferroni post-test,
p< 0.05,  p< 0.01,  p< 0.001. Results shown in (B-D) are from lumbar spinal cord sec-
tions. Data are representative of two to three independent studies in independent cultures, and
two to four mice per genotype per time point. All data in (A) are available on the GEO website
(http://www.ncbi.nlm.nih.gov/geo/) (Accession number GSE79245). Individual values for all
other quantifications are in S1 Data.
(TIF)
S5 Fig. Identification and validation of Klf6-dependent transcripts in oligodendrocyte line-
age cells. Data complement findings in Fig 4 and S1–S3 Tables. (A,B) Silencing strategy for
samples used in RNA-seq analysis. (A) Primary mouse OLP are isolated and expanded, then
nucleofected with siRNA specific for Klf6 or non-targeting (NT) control. Klf6-silenced OLP
and controls are harvested following attachment, or after an additional 18 h exposure to T3 (40
ng/ml) or vehicle, prior to any changes in viability as assessed via caspase cleavage assay (B).
(C) Expanded dataset for qPCR validation of RNA-seq results from primary mouse OLP (red),
iOL (blue), and shared genes (purple). See also Fig 4D. (D) Expanded dataset for sensitivity of
validated differentially expressed transcripts to Cntf treatment (100 ng/ml) in Oli-neu cells.
Colored areas indicate the time period before peak response of Klf6 to Cntf. Note also that
some Klf6-dependent genes are Cntf-independent (Plxnb3 and Stmn3 illustrated). See also
Fig 4E. (E) Results of qPCR analysis of primary mouse OLP subjected to Stat3 silencing as
described in Materials and Methods, followed by treatment with 40ng/ml T3 for up to 2 h. In
Stat3-silenced OLP cultures, there is no compensatory sensitivity of Klf6 to T3 treatment.
Results are presented as mean ± SEM. Statistics, Students t test (B,C), two-way ANOVA plus
Bonferroni test (E),  p< 0.05,  p< 0.01,  p< 0.001. Data shown are representative of two
to three independent studies in separate cultures. Individual values are in S1 Data.
(TIF)
S6 Fig. Validation of the gp130-Klf-importin axis in oligodendrocyte lineage cells. Data
complement results presented in Figs 5 and 6. (A) Confocal image of lumbar spinal cord of an
E16.5 wild-type mouse embryo labeled for Stat3 and the marker of ventral horn motor neu-
rons, Mnr. Immunoreactivity for Stat3 is ubiquitous, but is strongest within ventral Mnr+
motor neurons (arrowed). Stat3 also localizes less strongly to Olig2+ oligodendrocyte lineage
cells (see Fig 5F). (B–D) Results of confocal imaging analysis of spinal cords from embryos
with Stat3 inactivation targeted to oligodendrocyte lineage cells (Olig1Cre:Stat3fl/fl), and
Stat3fl/fl littermate controls. As shown in Fig 5G–5K, these mice display loss of differentiating
oligodendrocytes from E16.5 onwards. Panels presented here show that this loss occurs via
apoptosis (B). OLP proliferation is unaffected (C). As illustrated in Fig 5K and unlike mice
with Klf6 inactivation driven by the same Cre cassette, Olig1Cre:Stat3fl/fl embryos also display
progressive loss of Mnr+ motor neurons (D). (E) Confocal imaging analysis of Klf6-silenced
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and NT control mouse OLP pretreated with 2 μM caspase inhibitor Q-VD-OPh or vehicle 2 h,
then exposed to T3 for 18 h. Klf6-silenced cultures treated with Q-VD-OPh 2 μM display loss
of Impα5 expression, suggesting that loss of Impα5 in these cultures is not due simply to apo-
ptotic loss of Impα5-expressing cells. (F) Results of confocal analysis of primary mouse OLP
cultures silenced for Impα5 and non-targeting control, differentiated via T3 for 72 h, then
immunolabeled for cleaved caspase-3. Data complement findings in Fig 6E–6G, which show
that induction of differentiation and myelin markers is strongly reduced in cultures with a
defective Klf-importin axis. Results presented here confirm that failure of differentiation in
these cultures is associated with increased apoptosis. Data are representative of at least three
independent experiments in separate cultures, or at least three mice per genotype. Data shown
in (B–D) are from lumbar sections. Scalebar, (A) 25 μm. Statistics, (B–D) two-way ANOVA
plus Bonferroni test, (F) Student’s t test, p< 0.01, p< 0.001. Individual values are in
S1 Data.
(TIF)
S1 Table. RNA-seq profiling of Klf6-regulated transcripts in OLP. Results shown here com-
plement data in Figs 4 and S5 and in S2 and S3 Tables. Results of RNA-seq profiling of primary
mouse OLP silenced for Klf6 versus non-targeting control to identify Klf6-regulated tran-
scripts, as described in the text and illustrated in S5 Fig. Data from two separate cultures have
been filtered for statistically significant differential expression with FDR correction p< 0.05 (Q
value, shown). Results from iOL are in S2 Table. Transcripts shared by both OLP and iOL are
also shown in S3 Table. This analysis identifies 172 unique Klf6-regulated transcripts in OLP.
Regulated transcripts are presented together with FPKM values, fold change, Q value, Unigene
ID identifiers and PMID numbers for relevant references, and associated functions (summa-
rized in Fig 4B). Results are color-coded using the scheme illustrated in Figs 4–6 for primary
OLP (red) and shared transcripts (purple). Data are available on the GEO website (http://www.
ncbi.nlm.nih.gov/geo/) (Accession number GSE79245).
(XLSX)
S2 Table. RNA-seq identification of Klf6-regulated genes in iOL. Data here accompany find-
ings in Figs 4 and S5 and in S1 and S3 Tables. RNA-seq profiling results from primary mouse
iOL silenced for Klf6 versus non-targeting control. Data from two separate cultures have been
filtered for statistically significant differential expression with FDR correction p< 0.05 (Q
value, shown). Results from OLP are in S1 Table. Transcripts shared by both OLP and iOL are
also in S3 Table. This analysis identifies 51 unique Klf6-regulated transcripts in iOL. Regulated
transcripts are presented together with FPKM values for each condition, fold change, Q value,
Unigene ID identifiers and PMID numbers for relevant references, and associated functions
(summarized in Fig 4B). Results are color-coded using the scheme illustrated in Figs 4–6, for
primary iOL (blue) and shared transcripts (purple). Data are available on the GEO website
(http://www.ncbi.nlm.nih.gov/geo/) (Accession number GSE79245).
(XLSX)
S3 Table. RNA-seq profiling of Klf6-regulated transcripts shared by OLP and iOL. Findings
here extend and complement results shown in Figs 4 and S5 and in S1 and S2 Tables. RNA-seq
profiling data from primary mouse OLP and iOL silenced for Klf6 versus non-targeting control
to identify Klf6-regulated transcripts, as described in the text and illustrated in S5 Fig. Results
from two separate cultures per condition have been filtered for statistically significant differen-
tial expression with FDR correction p< 0.05 (Q value). Full datasets from OLP and iOL are
in S1 and S2 Tables, respectively. Transcripts shared by both OLP and iOL are shown here.
This analysis identifies 40 Klf6-regulated transcripts shared by both OLP and iOL. Regulated
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transcripts are presented together with Unigene ID identifiers and PMID numbers for relevant
references, and associated functions (summarized in Fig 4B). Results are color-coded using the
scheme illustrated in Figs 4–6, in which shared transcripts are colored purple. Note that since
FPKM values for each condition, fold change, and Q value are shown for all regulated tran-
scripts in OLP and iOL in S1 and S2 Tables, they are not shown again here. Data are available
on the GEO website (http://www.ncbi.nlm.nih.gov/geo/) (Accession number GSE79245).
(XLSX)
S4 Table. Results of ChIP-seq screening for Klf6 binding to promoters of prospective effec-
tors. Data shown here complement Fig 5 and illustrate results of ChIP-seq profiling of primary
mouse OLP and iOL subjected to chromatin immunoprecipitation for Klf6 versus input as
described in the text. Data from one of two representative studies are presented for both OLP
and iOL, filtered for statistical significance with FDR correction p< 0.05 (Q value, shown),
and for peak amplitude. Results presented include location and summit peak of chromatin
binding, fold enrichment over input, distance from nearest transcription start site, and Q value.
Data are also available on the GEO website (http://www.ncbi.nlm.nih.gov/geo/) (Accession
number GSE79245). Results are color-coded by distance from known transcriptional start sites
of annotated genes shown, from +5 kb to -15 kb. Genes also identified in RNA-seq experiments
are shown in bold (see S1–S3 Tables). Integration of data from the two ChIP-seq studies fil-
tered as described identifies 577 peaks of Klf6 chromatin binding called uniquely in OLP, 416
in iOL, and 337 peaks called in both populations.
(XLSX)
S5 Table. Identification of Klf6-dependent genes that are directly Klf6-regulated. This table
complements Figs 4 and 5 and S1–S4 Tables. It shows results of superimposition of RNA-seq
profiling of OLP and iOL silenced for Klf6 versus non-targeting control (from S1–S3 Tables
and Fig 4), and Klf6 ChIP-seq profiling of the same cell types (from S4 Table and Fig 5). Over-
lay of the RNA-seq and ChIP-seq datasets identifies 20 genes as prospective directly-regulated
Klf6-dependent effectors. Data are presented as gene names and associated functions, accom-
panied by Unigene ID identifiers and PMID numbers for relevant references. Results are color-
coded using the scheme illustrated in Figs 4–6 and S1–S3 Tables.
(XLSX)
S6 Table. Primer sequences for genotyping and qPCR. Additional details for the Materials
and Methods section. This table shows primer sequences for genotyping of mouse lines and for
qPCR for validation of RNA-seq data and maturation data presented in the manuscript.
(XLSX)
S1 Video. Related to Fig 1. Tremor and ataxia in Olig1Cre:Klf6fl/fl mice. Video sequence
showing two representative P11 Olig1Cre:Klf6fl/fl mutants (center and right), and a sex-
matched Klf6fl/fl littermate control (left). The mutants are smaller than the control and display
tremor and ataxia. All Olig1Cre:Klf6fl/fl pups display similar signs, which are progressive, and
none survive beyond 21 days of age. Data are typical of results from each genotype (at least 50
pups per genotype). A still image from this sequence is illustrated in Fig 1G.
(MPG)
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